News & Updates

Men and women with long-term consumption of lignans, phytoestrogens abundant in Western diets, are at lower risk of type 2 diabetes (T2D), and this is especially true for those with obesity and women who are premenopausal, according to a study.

In the treatment of critically ill patients with acute organ dysfunction, use of the SGLT-2 inhibitor dapagliflozin in addition to standard care does not appear to improve clinical outcomes, according to a study.

Pre-existing diabetes has been linked to threefold greater odds of stillbirth and perinatal mortality, with type 2 posing a greater threat than type1 diabetes, according to the results of the meta-analysis.

More than one-fifth of patients with acute cerebral ischaemia (ACI) appear to be receiving statins unnecessarily, which has the potential to cause higher than 5,600 adverse events (AEs) each year, including diabetes, myopathy, and eye disease, according to the results of a meta-analysis.

New drug applications approved by US FDA as of 16-31 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.